{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-086068","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2026-07-23T11:00:29+00:00","discovered_at":"2026-07-23T11:05:00.283455+00:00","generated_at":"2026-07-23T11:05:29.645365+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"United Therapeutics appoints Victor Dzau to Board of Directors","bullets":["Board expanded to 13 members; Victor Dzau, M.D., appointed effective July 22, 2026.","Dr. Dzau recently completed 12-year tenure as President of the National Academy of Medicine.","Initial grant: 380 RSUs and 1,190 stock options; pro-rata grant: 350 RSUs and 1,110 options.","No transactions exceeding $120,000 between Dr. Dzau and the company since last fiscal year.","Dr. Dzau will not serve on any Board committee initially."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-086068","json":"https://secwatch.observer/filing/0001104659-26-086068.json","markdown":"https://secwatch.observer/filing/0001104659-26-086068.md","text":"https://secwatch.observer/filing/0001104659-26-086068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926086068/0001104659-26-086068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926086068/tm2620809d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T11:05:29.645365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}